AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Licensing agreement for fentanyl patch inked.
2004 APR 1 - (NewsRx.com & NewsRx.net) -- Noven Pharmaceuticals, Inc., (NOVN) and Endo Pharmaceuticals, Inc., a wholly owned subsidiary of Endo Pharmaceuticals Holdings, Inc., (ENDP), have signed an agreement under which Noven will license the U.S. and Canadian rights to its developmental transdermal fentanyl patch to Endo.
The agreement also establishes an ongoing collaboration between the two companies for the development of additional prescription transdermal products.
Noven's fentanyl patch is a transdermal delivery system for the management of chronic pain. It is intended to be the generic equivalent of Johnson & Johnson's Duragesic (fentanyl transdermal system), which had U.S. sales of approximately $1.3 billion in 2003. An abbreviated new drug application for Noven's patch is pending at the U.S. Food and Drug Administration (FDA).
Noven received $8.0 million from Endo upon signing the agreement. Upon Endo's first commercial sale of the fentanyl patch, Noven is entitled to receive an additional payment ranging from $5.0-10.0 million, depending on the timing of launch and the number of generic ...
- Noven Provides Update on Developmental Fentanyl Patch.
- Press release article from: Business Wire September 28, 2005 700+ words
...the U.S. licensee of Noven's fentanyl patch, was also present at...approval of the generic fentanyl patch. Noven has approximately $13...balance sheet. Under the fentanyl patch license agreement, Noven and Endo have agreed...
- Noven and Endo announce licensing agreement for fentanyl patch.(Noven...
- Newspaper article from: BIOTECH Patent News March 1, 2004 700+ words
...transdermal products. Noven's fentanyl patch is a transdermal delivery...commercialization partner for our fentanyl patch," said Robert C. Strauss, Noven's president, CEO...commercial sale of the fentanyl patch, Noven is entitled to receive...
- Noven and Endo Announce Licensing Agreement for Fentanyl Patch; Agreement...
- Press release article from: Business Wire February 26, 2004 700+ words
...transdermal products. Noven's fentanyl patch is a transdermal delivery...commercialization partner for our fentanyl patch," said Robert C. Strauss, Noven's President, CEO...commercial sale of the fentanyl patch, Noven is entitled to receive...
- Noven Files Response to Fentanyl Patch Citizen Petition.
- Press release article from: Business Wire December 13, 2004 700+ words
...noven.com/cpresponse1.htm. Noven plans to submit additional comments...Johnson, in the near future. Noven's fentanyl patch is a transdermal delivery system...Abbreviated New Drug Application for Noven's patch is pending at the FDA...
- Noven Submits Response to Alza Citizen Petition on Fentanyl Patch.
- Press release article from: Business Wire December 27, 2004 700+ words
...comments, and a link to the subject citizen petition, are available on Noven's website at http://www.noven.com/cpresponse1.htm. Noven's fentanyl patch is a transdermal delivery system for the management of chronic pain. An...
- Noven Submits Response to London & Mead Citizen Petition on Fentanyl Patch.
- Press release article from: Business Wire January 3, 2005 700+ words
...comments, and a link to the subject citizen petition, are available on Noven's website at http://www.noven.com/cpresponse1.htm. Noven's fentanyl patch is a transdermal delivery system for the management of chronic pain. An...
- Licensing agreement for fentanyl patch inked.
- Newspaper article from: Biotech Business Week March 29, 2004 700+ words
...transdermal products. Noven's fentanyl patch is a transdermal delivery...commercial sale of the fentanyl patch, Noven is entitled to receive...received by that time. Noven has retained all rights to the fentanyl patch outside of the U...
- Endo Pharmaceuticals Provides Update On Its Developmental Transdermal Fentanyl...
- Press release article from: PR Newswire September 28, 2005 700+ words
...it will not approve Noven's currently pending...developmental transdermal fentanyl patch based on the FDA's...drug content in the Noven product versus the reference...current transdermal fentanyl patch inventory and approximately...license fee that Endo paid Noven in February ...
Source: HighBeam Research, Licensing agreement for fentanyl patch inked.